Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

出版年份 2018 全文链接

标题

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug

作者

关键词

-

出版物

PHARMACOLOGICAL RESEARCH

Volume 136, Issue -, Pages 140-150

出版商

Elsevier BV

发表日期

2018-09-14

DOI

10.1016/j.phrs.2018.09.007

向作者/读者发起求助以获取更多资源

Protocol

Reagent

Reprint

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

© Peeref 2019-2024. All rights reserved.